KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Intangibles (2016 - 2025)

Historic Intangibles for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $23.1 billion.

  • Amgen's Intangibles fell 1998.96% to $23.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $23.1 billion, marking a year-over-year decrease of 1998.96%. This contributed to the annual value of $27.7 billion for FY2024, which is 1514.05% down from last year.
  • Amgen's Intangibles amounted to $23.1 billion in Q3 2025, which was down 1998.96% from $24.6 billion recorded in Q2 2025.
  • Amgen's 5-year Intangibles high stood at $32.6 billion for Q4 2023, and its period low was $13.2 billion during Q3 2023.
  • Its 5-year average for Intangibles is $20.3 billion, with a median of $15.9 billion in 2021.
  • Its Intangibles has fluctuated over the past 5 years, first soared by 11992.4% in 2024, then plummeted by 1998.96% in 2025.
  • Amgen's Intangibles (Quarter) stood at $15.2 billion in 2021, then rose by 5.91% to $16.1 billion in 2022, then skyrocketed by 102.99% to $32.6 billion in 2023, then dropped by 15.14% to $27.7 billion in 2024, then decreased by 16.46% to $23.1 billion in 2025.
  • Its Intangibles stands at $23.1 billion for Q3 2025, versus $24.6 billion for Q2 2025 and $25.7 billion for Q1 2025.